{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:52:08Z","timestamp":1778925128188,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006069","name":"Krebsliga Beider Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003006","name":"Eidgen\u00f6ssische Technische Hochschule Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"Universit\u00e4t Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-1067-y","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T07:34:30Z","timestamp":1542699270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Marcus","family":"Vetter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Landin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Maria","family":"Szczerba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Castro-Giner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Gkountela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Krol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Scherrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Balmelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Malinovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kurzeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Paul","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Rochlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-6918","authenticated-orcid":false,"given":"Nicola","family":"Aceto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trecan.2015.07.006","volume":"1","author":"N Aceto","year":"2015","unstructured":"Aceto N, Toner M, Maheswaran S, Haber DA. En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition. Trends Cancer. 2015;1:44\u201352.","journal-title":"Trends Cancer"},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"dju066","DOI":"10.1093\/jnci\/dju066","volume":"106","author":"B Rack","year":"2014","unstructured":"Rack B, Schindlbeck C, J\u00fcckstock J, Andergassen U, Hepp P, Zwingers T, et al. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst. 2014;106:dju066.","journal-title":"J Natl Cancer Inst"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781\u201391.","journal-title":"N Engl J Med"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/bcr2907","volume":"13","author":"M Giuliano","year":"2011","unstructured":"Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, Mego M, et al. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011;13:R67.","journal-title":"Breast Cancer Res"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322.","journal-title":"Cell"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nm.4239","volume":"23","author":"L Carter","year":"2017","unstructured":"Carter L, Rothwell DG, Mesquita B, Smowton C, Leong HS, Fernandez-Gutierrez F, et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat Med. 2017;23:114\u20139.","journal-title":"Nat Med"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, et al. Cancer therapy: ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014;345:216\u201320.","journal-title":"Science"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/15384047.2015.1026508","volume":"16","author":"JT Kaifi","year":"2015","unstructured":"Kaifi JT, Kunkel M, Dicker DT, Joude J, Allen JE, Das A, et al. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver. Cancer Biol Ther. 2015;16:690\u20138.","journal-title":"Cancer Biol Ther"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3816\/CBC.2007.n.004","volume":"7","author":"M Cristofanilli","year":"2007","unstructured":"Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer. 2007;7:471\u20139.","journal-title":"Clin Breast Cancer"},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"e0138032","DOI":"10.1371\/journal.pone.0138032","volume":"10","author":"L Xu","year":"2015","unstructured":"Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, et al. Optimization and evaluation of a novel size based circulating tumor cell isolation system. PLoS One. 2015;10:e0138032.","journal-title":"PLoS One"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1056\/NEJMp1202619","volume":"366","author":"M Whitaker","year":"2012","unstructured":"Whitaker M, Guo J, Kehoe T, Benson G. Bisphosphonates for osteoporosis\u2014where do we go from here? N Engl J Med. 2012;366:2048\u201351.","journal-title":"N Engl J Med"},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"DA Hanley","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract. 2012;66:1139\u201346.","journal-title":"Int J Clin Pract"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10585-013-9624-3","volume":"31","author":"ML Blake","year":"2014","unstructured":"Blake ML, Tometsko M, Miller R, Jones JC, Dougall WC. RANK expression on breast cancer cells promotes skeletal metastasis. Clin Exp Metastasis. 2014;31:233\u201345.","journal-title":"Clin Exp Metastasis"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-014-2955-1","volume":"145","author":"BM Pfitzner","year":"2014","unstructured":"Pfitzner BM, Branstetter D, Loibl S, Denkert C, Lederer B, Schmitt WD, et al. RANK expression as a prognostic and predictive marker in breast cancer. Breast Cancer Res Treat. 2014;145:307\u201315.","journal-title":"Breast Cancer Res Treat"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature19328","volume":"537","author":"NV Jordan","year":"2016","unstructured":"Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102\u20136.","journal-title":"Nature"},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10549-011-1632-x","volume":"129","author":"N Houssami","year":"2011","unstructured":"Houssami N, Macaskill P, Balleine RL, Bilous M, Pegram MD. HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Res Treat. 2011;129:659\u201374.","journal-title":"Breast Cancer Res Treat"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1158\/1055-9965.EPI-06-0191","volume":"15","author":"WF Anderson","year":"2006","unstructured":"Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev. 2006;15:1899\u2013905.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1067_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198608283150906","volume":"315","author":"HO Adami","year":"1986","unstructured":"Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986;315:559\u201363.","journal-title":"N Engl J Med"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-016-3983-9","volume":"160","author":"H Fredholm","year":"2016","unstructured":"Fredholm H, Magnusson K, Lindstrom LS, Garmo H, Falt SE, Lindman H, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat. 2016;160:131\u201343.","journal-title":"Breast Cancer Res Treat"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrc2349","volume":"8","author":"A Bleyer","year":"2008","unstructured":"Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.3892\/ol.2017.6000","volume":"13","author":"M Koleckova","year":"2017","unstructured":"Koleckova M, Kolar Z, Ehrmann J, Korinkova G, Trojanec R. Age-associated prognostic and predictive biomarkers in patients with breast cancer. Oncol Lett. 2017;13:4201\u20137.","journal-title":"Oncol Lett"},{"issue":"Pt 5","key":"1067_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/000456329903600503","volume":"36","author":"MJCA Duffy","year":"1999","unstructured":"Duffy MJCA. 15-3 and related mucins as circulating markers in breast cancer. Ann Clin Biochem. 1999;36(Pt 5):579\u201386.","journal-title":"Ann Clin Biochem"},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nbt.2892","volume":"32","author":"JG Lohr","year":"2014","unstructured":"Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014;32:479\u201384.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1067_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-1067-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:22:11Z","timestamp":1574194931000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-1067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-1067-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study participants agreed and signed a written informed consent. The study was performed under the protocols EKNZ BASEC 2016-00067 and EK 321\/10, which received ethical and institutional review board approvals before study initiation (Ethics Committee northwest\/central Switzerland [EKNZ]). This study was performed in compliance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NA, BMS and FCG are listed as inventors in a patent application filed by the University of Basel, entitled \u201cInhibitors of bone resorption for treatment of metastasis\u201d (#EP18161098). The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"141"}}